JenniferMaMD

PubMed

• Artificial-intelligence-driven measurements of brain metastases' response to SRS compare favorably with current manual standards of assessment.
  Kayla Prezelski, Dylan G Hsu, Luke Del Balzo, Erica Heller, Jennifer Ma, Luke R G Pike, Åse Ballangrud, Michalis Aristophanous> ;Neuro-Oncology Advances. 2024 Feb 19
• 1 citations
  Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma.
  Chami, P., Diab, Y., Jarnagin, W., Hajj, J., El Homsi, M., Khalil, D., Azhari, H., Abou-Alfa, G., Harding, J., Ma, J., Reyngold, M., Crane, C., Hajj, C.> ;International Journal of Molecular Sciences. 2023 Nov 26
• What to Expect When You're Expecting: Managing Oral Cavity Cancer in the Setting of a Second Trimester Pregnancy.
  Jennifer Ma, Nancy Y Lee> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Nov 1
• Quality of Life Before and After Treatment of Cutaneous Metastases with Palliative Radiotherapy.
  Rachel E. Reingold, Brooke E. Corbett, Nina R. Blank, Rachel A. Day, Michael J. McManus, Jennifer Ma, Stephen W. Dusza, Mario E. Lacouture, Christopher A. Barker, Alin...> ;Journal of the American Academy of Dermatology. 2021 Nov 23
• 126 citations
  The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
  Jennifer Ma, Jeremy Setton, Nancy Y. Lee, Nadeem Riaz, Simon N. Powell> ;Nature Communications. 2018 Aug 17
• 26 citations
  Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.
  Jennifer Ma, Jeremy Setton, Luc G. T. Morris, Pedro Blecua Carrillo Albornoz, Christopher A. Barker, Benjamin H. Lok, Eric J. Sherman, Nora Katabi, Kathryn Beal, Ian G...> ;Oncotarget. 2017 Feb 7
• 32 citations
  Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy
  Kenneth L. Pitter, Dana L. Casey, Yue C Lu, Margaret Hannum, Zhigang Zhang, Xinmao Song, Isabella Pecorari, Biko McMillan, Jennifer Ma, Robert M. Samstein, Isaac X Pei...> ;Journal of the National Cancer Institute. 2021 Mar 1
• 11 citations
  Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
  Imane El Dika, Marinela Capanu, Joanne F. Chou, James J. Harding, Michele Ly, Anna D. Hrabovsky, Richard K. G. Do, Jinru Shia, Brittanie M Millang, Jennifer Ma, Eileen...> ;Cancer Medicine. 2020 Aug 25
• 29 citations
  Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
  Dan Fan, Jennifer Ma, Andrew C. Bell, Andries H. Groen, Kyrie S. Olsen, Benjamin H. Lok, Jonathan E. Leeman, E.S. Anderson, Nadeem Riaz, Sean McBride, Ian Ganly, Ashok...> ;Cancer. 2020 Jan 15
• 80 citations
  ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer
  Qiang Li, Alexis W. Damish, Zoë Frazier, David Liu, Elizaveta Reznichenko, Atanas Kamburov, Andrew C. Bell, Huiyong Zhao, Emmet Jordan, S. Paul Gao, Jennifer Ma, Phili...> ;Clinical Cancer Research. 2019 Feb 1
• 9 citations
  Local recurrence and quality of life after adjuvant radiation therapy in high-risk squamous cell carcinoma.
  B.Y. Yan, S.K. Kim, Jennifer Ma, Christopher A. Barker> ;The British Journal of Dermatology. 2019 Feb 1
• 28 citations
  Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.
  Jennifer Ma, James Laird, K. Chau, Monica Chelius, Benjamin H. Lok, Joachim Yahalom> ;Cancer Medicine. 2019 Jan 1
• 55 citations
  Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.
  James Laird, Benjamin H. Lok, Jennifer Ma, Andrew C. Bell, Elisa de Stanchina, John T. Poirier, Charles M. Rudin> ;Clinical Cancer Research. 2018 Oct 15
• 9 citations
  Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot
  Jennifer Ma, Benjamin H. Lok, Jingfeng Zong, Stanley I. Gutiontov, Xin Cai, Andrew C. Bell, Marina Shcherba, Han Xiao, Eric J Sherman, Chiaojung Jillian Tsai, Nadeem R...> ;International Journal of Particle Therapy. 2018 Jul 26
• 14 citations
  Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
  James Laird, Jennifer Ma, Karen Chau, Monica Chelius, Weiji Shi, Zhigang Zhang, Benjamin H. Lok, Joachim Yahalom> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Mar 1
• 30 citations
  Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer
  Benjamin H. Lok, Jennifer Ma, A. Foster, C.A. Perez, Weiji Shi, Zhigang Zhang, Bob T. Li, Charles M. Rudin, Andreas Rimner, Abraham J. Wu> ;Advances in Radiation Oncology. 2017 Aug 8
• 19 citations
  Phase II Study of First‐Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
  Ghassan K. Abou-Alfa, Jean-Frédéric Blanc, Steven A. Miles, Tom M. Ganten, Jörg Trojan, Jonathan Cebon, Andre K. D. Liem, Lara Lipton, Charu Gupta, Benjamin Wu, Michae...> ;The Oncologist. 2017 Jul 1
• 20 citations
  The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era
  Zachary S. Zumsteg, Benjamin H. Lok, Allen S. Ho, Esther Drill, Zhigang Zhang, Nadeem Riaz, Stephen L. Shiao, Jennifer Ma, Sean McBride, C. Jillian Tsai, Shrujal S. Ba...> ;Cancer. 2017 Apr 15
• 26 citations
  Challenges and opportunities in primary CNS lymphoma: A systematic review.
  Mariana Nassif Kerbauy, Fabio Y. Moraes, Benjamin H. Lok, Jennifer Ma, Lucila Nassif Kerbauy, Daniel E. Spratt, Fabio P.S. Santos, Guilherme Fleury Perini, Alejandro B...> ;Radiotherapy and Oncology. 2017 Mar 1
• 18 citations
  Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).
  Ghassan K. Abou-Alfa, Chia Jui Yen, Chih-Hung Hsu, Joseph A. O'Donoghue, Volkan Beylergil, Shutian Ruan, Neeta Pandit-Taskar, Bolorsukh Gansukh, Serge K. Lyashchenko, ...> ;Cancer Chemotherapy and Pharmacology. 2017 Jan 24
• 73 citations
  A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.
  Ghassan K. Abou-Alfa, Marinela Capanu, Eileen M. O'Reilly, Jennifer Ma, Joanne F. Chou, Bolorsukh Gansukh, Jinru Shia, Marcia F. Kalin, Seth S. Katz, L. Abad, Diane Re...> ;Journal of Hepatology. 2014 Feb 1
• 84 citations
  A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
  Jean Kyung Lee, Marinela Capanu, Eileen M. O'Reilly, Jennifer Ma, Joanne F. Chou, Jinru Shia, Seth S. Katz, Bolorsukh Gansukh, Diane Reidy-Lagunes, Neil H. Segal, Kenn...> ;British Journal of Cancer. 2013 Aug 20
• Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma.
  Dwight H. Owen, Eileen M. O'Reilly, Celina Ang, Jennifer Ma, Richard K. G. Do, Ghassan K. Abou-Alfa> ;Gastrointestinal Cancer Research. 2013 May 1
• 10 citations
  A Nonrandomized, Phase II Study of Sequential Irinotecan and Flavopiridol in Patients With Advanced Hepatocellular Carcinoma.
  Celina Ang, Eileen M. O'Reilly, Richard D. Carvajal, Marinela Capanu, Mithat Gonen, Laurence Doyle, Ronald Ghossein, Lawrence H. Schwartz, G. Jacobs, Jennifer Ma, Gary...> ;Gastrointestinal Cancer Research. 2012 Nov 1
• Join now to see all